iRadimed Corp. (IRMD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$83.45-3.63%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · IRMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 86.3 | 83.8 | 73.2 | 65.6 | 53.3 | 41.8 | 31.7 | 38.5 | 30.4 | 23.1 | 32.5 | 31.6 | 15.7 |
| Total Revenues | 86.3 | 83.8 | 73.2 | 65.6 | 53.3 | 41.8 | 31.7 | 38.5 | 30.4 | 23.1 | 32.5 | 31.6 | 15.7 |
| Cost of Revenues | 20.8 | 19.5 | 16.9 | 15.4 | 12.0 | 9.8 | 8.1 | 8.8 | 7.2 | 5.6 | 6.2 | 5.8 | 3.4 |
| Gross Profit | 65.5 | 64.3 | 56.3 | 50.2 | 41.3 | 32.0 | 23.6 | 29.7 | 23.2 | 17.5 | 26.3 | 25.8 | 12.2 |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 3.1 | 3.0 | 2.8 | 2.9 | 2.3 | 1.9 | 1.9 | 1.4 | 1.5 | 1.7 | 1.3 | 1.8 | 1.1 |
| Operating Income | 27.6 | 26.1 | 22.0 | 20.0 | 15.6 | 9.8 | (0.8) | 8.6 | 6.0 | 1.3 | 10.9 | 11.5 | 3.1 |
| Earnings from Continuing Operations | |||||||||||||
| Interest & Investment Income | — | 2.0 | 2.2 | 1.9 | 0.6 | 0.0 | 0.1 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | — |
| Other Non-Operating Income / Expenses | 2.2 | 2.2 | 2.3 | 1.7 | 0.6 | 0.0 | 0.1 | 0.4 | 0.2 | 0.1 | 0.0 | 0.1 | (0.0) |
| EBT, Incl. Unusual Items | 29.7 | 28.4 | 24.3 | 21.7 | 16.2 | 9.8 | (0.6) | 9.0 | 6.2 | 1.4 | 11.0 | 11.6 | 3.0 |
| Income Tax Expense | 6.7 | 5.9 | 5.0 | 4.5 | 3.4 | 0.5 | (2.0) | (0.6) | (0.1) | 0.9 | 3.7 | 4.1 | 1.0 |
| Net Income | |||||||||||||
| Net Income | 23.1 | 22.5 | 19.2 | 17.2 | 12.8 | 9.3 | 1.4 | 9.6 | 6.3 | 0.5 | 7.2 | 7.5 | 2.1 |
| Per Share | |||||||||||||
| Basic EPS | 1.80 | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | 0.59 | 0.05 | 0.67 | 0.68 | 0.23 |
| Diluted EPS | 1.79 | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | 0.52 | 0.04 | 0.60 | 0.60 | 0.20 |
| Revenue per Share | 6.71 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 12.8 | 12.7 | 12.7 | 12.6 | 12.6 | 12.3 | 12.1 | 11.3 | 10.8 | 10.6 | 10.8 | 11.0 | 8.7 |
| Diluted Weighted Avg Shares | 12.9 | 12.9 | 12.8 | 12.7 | 12.6 | 12.6 | 12.4 | 12.3 | 12.1 | 11.7 | 12.0 | 12.6 | 10.2 |
| Supplemental | |||||||||||||
| EBITDA | — | 27.3 | 22.8 | 20.8 | 16.2 | 10.3 | 0.6 | 9.9 | 7.1 | 2.6 | 11.9 | 12.3 | 3.2 |
| EBIT | 27.6 | 26.1 | 22.0 | 20.0 | 15.6 | 9.8 | (0.8) | 8.6 | 6.0 | 1.3 | 10.9 | 11.5 | 3.1 |
| Effective Tax Rate | 22.5% | — | — | 20.9% | 20.7% | 5.2% | 321.9% | -6.5% | -1.7% | 64.2% | 34.1% | 35.3% | 32.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.